High Tech Pharm Co., Ltd. (KOSDAQ:106190)

South Korea flag South Korea · Delayed Price · Currency is KRW
14,610
0.00 (0.00%)
Feb 13, 2025, 9:00 AM KST
53.79%
Market Cap 157.69B
Revenue (ttm) 81.56B
Net Income (ttm) 14.56B
Shares Out 10.63M
EPS (ttm) 2,055.66
PE Ratio 7.21
Forward PE n/a
Dividend 100.00 (0.67%)
Ex-Dividend Date Dec 27, 2024
Volume 10,537
Average Volume 52,381
Open 14,460
Previous Close 14,610
Day's Range 14,420 - 14,700
52-Week Range 8,660 - 19,280
Beta 0.85
RSI 50.86
Earnings Date Feb 4, 2025

About High Tech Pharm

High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1998
Employees 65
Stock Exchange KOSDAQ
Ticker Symbol 106190
Full Company Profile

Financial Performance

In 2023, High Tech Pharm's revenue was 76.77 billion, a decrease of -25.43% compared to the previous year's 102.95 billion. Earnings were 8.08 billion, an increase of 37.52%.

Financial Statements

News

There is no news available yet.